These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 16254858)
1. [Long-term evolution of the doses of Botulinum toxin used in laryngeal and cervical dystonias]. García-Torres MA; Echeverría-Urabayen A; Contreras A; Carnal-Martín P; García-Ruiz Espiga PJ Rev Neurol; 2005 Nov 1-15; 41(9):525-6. PubMed ID: 16254858 [TBL] [Abstract][Full Text] [Related]
2. [Progression of botulinum toxin type A dosage in craniocervical dystonias. An eight year comparative study]. Echeverría Urabayen A; Fanjul S; Meseguer E; García Ruiz Espiga PJ Rev Neurol; 2004 Mar 16-31; 38(6):511-3. PubMed ID: 15054712 [TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin in the treatment of dystonias--a hospital based study. Gupta M; Singh G; Khwaja G J Assoc Physicians India; 2003 May; 51():447-53. PubMed ID: 12974424 [TBL] [Abstract][Full Text] [Related]
4. Use of botulinum toxin in the treatment of cervical dystonia. Poewe W; Wissel J Baillieres Clin Neurol; 1993 Apr; 2(1):179-85. PubMed ID: 8143072 [TBL] [Abstract][Full Text] [Related]
5. Botulinum toxins in the treatment of primary focal dystonias. Truong D J Neurol Sci; 2012 May; 316(1-2):9-14. PubMed ID: 22336699 [TBL] [Abstract][Full Text] [Related]
6. Dosage changes in patients with long-term botulinum toxin use for laryngeal dystonia. Birkent H; Maronian N; Waugh P; Merati AL; Perkel D; Hillel AD Otolaryngol Head Neck Surg; 2009 Jan; 140(1):43-7. PubMed ID: 19130960 [TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin treatment of occupational and focal hand dystonia. Karp BI Mov Disord; 2004 Mar; 19 Suppl 8():S116-9. PubMed ID: 15027063 [TBL] [Abstract][Full Text] [Related]
8. Fast voluntary neck movements in patients with cervical dystonia: a kinematic study before and after therapy with botulinum toxin type A. Gregori B; Agostino R; Bologna M; Dinapoli L; Colosimo C; Accornero N; Berardelli A Clin Neurophysiol; 2008 Feb; 119(2):273-80. PubMed ID: 18063411 [TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period. Hsiung GY; Das SK; Ranawaya R; Lafontaine AL; Suchowersky O Mov Disord; 2002 Nov; 17(6):1288-93. PubMed ID: 12465070 [TBL] [Abstract][Full Text] [Related]
11. Comparison of Botox with a Chinese type A botulinum toxin. Tang X; Wan X Chin Med J (Engl); 2000 Sep; 113(9):794-8. PubMed ID: 11776072 [TBL] [Abstract][Full Text] [Related]
12. Long-term results and prognostic factors in the treatment of achalasia with botulinum toxin. Neubrand M; Scheurlen C; Schepke M; Sauerbruch T Endoscopy; 2002 Jul; 34(7):519-23. PubMed ID: 12170400 [TBL] [Abstract][Full Text] [Related]
13. Local treatment of dystonia and spasticity with injections of botulinum-A toxin. Calne S Axone; 1993 Jun; 14(4):85-8. PubMed ID: 8274387 [TBL] [Abstract][Full Text] [Related]
15. Focal dystonia in musicians: treatment strategies and long-term outcome in 144 patients. Jabusch HC; Zschucke D; Schmidt A; Schuele S; Altenmüller E Mov Disord; 2005 Dec; 20(12):1623-6. PubMed ID: 16078237 [TBL] [Abstract][Full Text] [Related]
16. [Botulinum toxin in blepharospasm, in hemifacial spasm, and in cervical dystonia: results in 33 patients]. Novis SA; De Mattos JP; De Rosso AL Arq Neuropsiquiatr; 1995 Sep; 53(3-A):403-10. PubMed ID: 8540813 [TBL] [Abstract][Full Text] [Related]
17. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin. Van den Bergh P; Francart J; Mourin S; Kollmann P; Laterre EC Muscle Nerve; 1995 Jul; 18(7):720-9. PubMed ID: 7783762 [TBL] [Abstract][Full Text] [Related]